The company is working on a serum adapted to the new variant of the coronavirus. It also announces that its current vaccine is “always effective” against the Omicron variant after “three doses”.
Pfizer / BioNTech is preparing a vaccine suitable for the Omicron variant of Covid-19, the company announced Wednesday, December 8. This one is expected “in March“. According to her, the current vaccine would also be “always efficient“Against the Omicron variant after”three doses“.
SEE ALSO – Pfizer France Vaccine Director explains how the vaccine could be adapted to the Omicron variant